These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 14968717)
1. Intrauterine stem cell therapy. Fisk NM; Chan J; O'Donoghue K Ann Acad Med Singap; 2003 Sep; 32(5 Suppl):S8-10. PubMed ID: 14968717 [No Abstract] [Full Text] [Related]
2. Impact of three genetic musculoskeletal diseases: a comparative synthesis of achondroplasia, Duchenne muscular dystrophy and osteogenesis imperfecta. Dogba MJ; Rauch F; Douglas E; Bedos C Health Qual Life Outcomes; 2014 Oct; 12():151. PubMed ID: 25649344 [TBL] [Abstract][Full Text] [Related]
3. Myogenic potential of fetal mesenchymal stem cells. Chan J; O'Donoghue K; Kennea N; de la Fuente J; Kumar S; Morgan J; Fisk N Ann Acad Med Singap; 2003 Sep; 32(5 Suppl):S11-3. PubMed ID: 14968718 [No Abstract] [Full Text] [Related]
11. [Advance in therapy for Duchenne/Becker muscular dystrophy]. Xu TT; Lan D Zhongguo Dang Dai Er Ke Za Zhi; 2015 Mar; 17(3):294-8. PubMed ID: 25815505 [TBL] [Abstract][Full Text] [Related]
12. Cell based therapy for Duchenne muscular dystrophy. Farini A; Razini P; Erratico S; Torrente Y; Meregalli M J Cell Physiol; 2009 Dec; 221(3):526-34. PubMed ID: 19688776 [TBL] [Abstract][Full Text] [Related]
13. Stem cell transplantation before birth - a realistic option for treatment of osteogenesis imperfecta? Westgren M; Götherström C Prenat Diagn; 2015 Sep; 35(9):827-32. PubMed ID: 25962526 [TBL] [Abstract][Full Text] [Related]
14. Perspectives of stem cell therapy in Duchenne muscular dystrophy. Meregalli M; Farini A; Belicchi M; Parolini D; Cassinelli L; Razini P; Sitzia C; Torrente Y FEBS J; 2013 Sep; 280(17):4251-62. PubMed ID: 23206279 [TBL] [Abstract][Full Text] [Related]
15. Human Foetal Mesenchymal Stem Cells. Götherström C Best Pract Res Clin Obstet Gynaecol; 2016 Feb; 31():82-7. PubMed ID: 26725704 [TBL] [Abstract][Full Text] [Related]
16. Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Le Blanc K; Götherström C; Ringdén O; Hassan M; McMahon R; Horwitz E; Anneren G; Axelsson O; Nunn J; Ewald U; Nordén-Lindeberg S; Jansson M; Dalton A; Aström E; Westgren M Transplantation; 2005 Jun; 79(11):1607-14. PubMed ID: 15940052 [TBL] [Abstract][Full Text] [Related]
17. [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation]. Zhang C; Feng HY; Huang SL; Fang JP; Xiao LL; Yao XL; Chen C; Ye X; Zeng Y; Lu XL; Wen JM; Zhang WX; Li Z; Feng SW; Xu HG; Huang K; Zhou DH; Chen W; Xie YM; Xi J; Zhang M; Li Y; Liu Y Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):399-405. PubMed ID: 16086277 [TBL] [Abstract][Full Text] [Related]
18. Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Duchenne Muscular Dystrophy: Safety and Feasibility Study in India. Rajput BS; Chakrabarti SK; Dongare VS; Ramirez CM; Deb KD J Stem Cells; 2015; 10(2):141-56. PubMed ID: 27125141 [TBL] [Abstract][Full Text] [Related]
19. Function induced modifications of gene expression: an alternative approach to gene therapy of Duchenne muscular dystrophy. Vrbová G J Muscle Res Cell Motil; 2004; 25(2):187-92. PubMed ID: 15360134 [TBL] [Abstract][Full Text] [Related]
20. Patient-tailored application for Duchene muscular dystrophy on mdx mice based induced mesenchymal stem cells. Jeong J; Shin K; Lee SB; Lee DR; Kwon H Exp Mol Pathol; 2014 Oct; 97(2):253-8. PubMed ID: 25102299 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]